Publicis acquires In-Sync
pharmafile | April 6, 2010 | News story | Medical Communications | agency, medical communications, publicis
Global communications group Publicis has acquired Toronto-based In-Sync, a company specialising in healthcare market research.
In-Sync will become part of Publicis Healthcare Communications Group (PHCG). In-Sync is a market research consultancy offering a fully integrated suite of innovative, quantitative and qualitative branded products to leading biopharma companies worldwide.
Publicis says adding In-Sync to its offering will strengthen PHCG’s edge by providing clients greater customer insight in the healthcare space.
In-Sync will maintain its current location and name and will continue to be led by founding partner and President Janet Winkler. The agency will report to Sam Welch, chief operating officer of PHCG North America.
Winkler founded In-Sync in 1989, later focusing on the health and wellness space, which is the core focus of its business today. The agency’s work encompasses market research, brand strategy, and management consulting, and adds to these the social studies of human groups and individuals, using its proprietary 360˚ Insight Engine.
Their client list includes many of the top pharmaceutical companies.
Nick Colucci, President and chief executive of PHCG, said: “Our heathcare network is strong and growing in part by finding value-creating acquisitions such as In-Sync, which bring tremendous strategy and innovative solutions to our biopharma clients and their brands.” Colucci continued, “The In-Sync team is already an impressive and highly sought after company, but we believe they will grow exponentially once they become part of our global network.”
Winkler says: “Joining PHCG enables us to extend our global presence and expand client value through the Group’s full scope of talent, resources and service.” She continued, “We look forward to delivering continued outstanding work to our current clients. We are also excited by the opportunity to more seamlessly integrate customer insight and branding with the ultimate goal of helping our clients better deliver against the needs of their customers.”
Welch says: “For clients looking to establish new brands or accelerate the growth of an existing one, In-Sync not only is a tremendous asset in itself, but also builds on the incredible foundation existing in our current strategic agencies. Leveraged on a global scale, we believe that In-Sync’s capabilities not only are transformative to the healthcare industry, they align with the future direction of PHCG.”
Related Content
Men’s health – a new report from the Department of Health and Social Care
The UK Department of Health and Social Care has published a new report entitled Men’s …
PlasmidFactory founder Dr. Martin Schleef honoured with the NRW Innovation Award 2025
The founder and long-standing CEO of PlasmidFactory, Dr. Martin Schleef, was honoured in Düsseldorf with …
Apiary invests in life sciences SEO pioneer PIO to support global expansion
Private equity firm Apiary Capital has invested in performance-io (PIO), a specialist life sciences performance …
